ITEM METADATA RECORD
Title: Lanreotide Reduces Liver Volume, but Might not Improve Muscle Wasting or Weight Loss, in Patients with Symptomatic Polycystic Liver Disease
Authors: Temmerman, Frederik ×
Ho, Thien Ahn
Vanslembrouck, Ragna
Coudyzer, Walter
Billen, Jaak
Dobbels, Fabienne
van Pelt, Jos
Bammens, Bert
Pirson, Yves
Nevens, Frederik #
Issue Date: Dec-2015
Publisher: W.B. Saunders for the American Gastroenterological Association
Series Title: Clinical Gastroenterology and Hepatology vol:13 issue:13 pages:2353-2359.e1
Article number: S1542-3565(15)00789-2
Abstract: Polycystic liver disease (PCLD) can induce malnutrition due to extensive hepatomegaly and patients might require liver transplantation. Six months of treatment with the somatostatin analogue lanreotide (120 mg) reduces liver volume. We investigated the efficacy of a lower dose of lanreotide and its effects on nutritional status.
URI: 
ISSN: 1542-3565
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Laboratory of Nephrology
Hepatology
Radiology
Clinical and Experimental Endocrinology
Academic Centre for Nursing and Midwifery
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
Lanreotide Reduces Liver Volume, but Might not Improve Muscle Wasting or Weight Loss, in Patients with Symptomatic Polycystic Liver Disease.pdf Published 761KbAdobe PDFView/Open Request a copy

These files are only available to some KU Leuven Association staff members

 




All items in Lirias are protected by copyright, with all rights reserved.

© Web of science